SEC Form 4 · accession 0001140361-16-078015
BIOLIFE SOLUTIONS INC · BLFS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Karen A. Foster
Officer — Vice President of Operations
Period of report
Apr 13, 2016
Accepted (ET)
Aug 26, 2016 · 7:14 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000834365
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $1.90 | Apr 13, 2016 | A | 100,000 | A | — | Apr 13, 2026 | Common Stock | 100,000 | 100,000 | D |
Explanation of responses
- F1The options vest 25% on the first anniversary of the grant date, 2,083 share installments in each of the 35 months thereafter and 2,095 shares on April 13, 2020.